1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Cell-Free DNA (cf-DNA) Testing Revenue
1.4 Market Analysis by Type
1.4.1 Global Cell-Free DNA (cf-DNA) Testing Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Donor-derived
1.4.3 Circulating
1.4.4 Cell-free
1.5 Market by Application
1.5.1 Global Cell-Free DNA (cf-DNA) Testing Market Share by Application: 2021-2026
1.5.2 Oncology
1.5.3 Gynecology
1.5.4 Transplantation
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Cell-Free DNA (cf-DNA) Testing Market
1.8.1 Global Cell-Free DNA (cf-DNA) Testing Market Status and Outlook (2015-2026)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Cell-Free DNA (cf-DNA) Testing Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global Cell-Free DNA (cf-DNA) Testing Revenue Market Share by Manufacturers (2015-2020)
2.3 Global Cell-Free DNA (cf-DNA) Testing Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Cell-Free DNA (cf-DNA) Testing Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Cell-Free DNA (cf-DNA) Testing Sales Volume Market Share by Region (2015-2020)
3.2 Global Cell-Free DNA (cf-DNA) Testing Sales Revenue Market Share by Region (2015-2020)
3.3 North America Cell-Free DNA (cf-DNA) Testing Sales Volume
3.3.1 North America Cell-Free DNA (cf-DNA) Testing Sales Volume Growth Rate (2015-2020)
3.3.2 North America Cell-Free DNA (cf-DNA) Testing Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 East Asia Cell-Free DNA (cf-DNA) Testing Sales Volume
3.4.1 East Asia Cell-Free DNA (cf-DNA) Testing Sales Volume Growth Rate (2015-2020)
3.4.2 East Asia Cell-Free DNA (cf-DNA) Testing Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe Cell-Free DNA (cf-DNA) Testing Sales Volume (2015-2020)
3.5.1 Europe Cell-Free DNA (cf-DNA) Testing Sales Volume Growth Rate (2015-2020)
3.5.2 Europe Cell-Free DNA (cf-DNA) Testing Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 South Asia Cell-Free DNA (cf-DNA) Testing Sales Volume (2015-2020)
3.6.1 South Asia Cell-Free DNA (cf-DNA) Testing Sales Volume Growth Rate (2015-2020)
3.6.2 South Asia Cell-Free DNA (cf-DNA) Testing Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Southeast Asia Cell-Free DNA (cf-DNA) Testing Sales Volume (2015-2020)
3.7.1 Southeast Asia Cell-Free DNA (cf-DNA) Testing Sales Volume Growth Rate (2015-2020)
3.7.2 Southeast Asia Cell-Free DNA (cf-DNA) Testing Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.8 Middle East Cell-Free DNA (cf-DNA) Testing Sales Volume (2015-2020)
3.8.1 Middle East Cell-Free DNA (cf-DNA) Testing Sales Volume Growth Rate (2015-2020)
3.8.2 Middle East Cell-Free DNA (cf-DNA) Testing Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.9 Africa Cell-Free DNA (cf-DNA) Testing Sales Volume (2015-2020)
3.9.1 Africa Cell-Free DNA (cf-DNA) Testing Sales Volume Growth Rate (2015-2020)
3.9.2 Africa Cell-Free DNA (cf-DNA) Testing Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.10 Oceania Cell-Free DNA (cf-DNA) Testing Sales Volume (2015-2020)
3.10.1 Oceania Cell-Free DNA (cf-DNA) Testing Sales Volume Growth Rate (2015-2020)
3.10.2 Oceania Cell-Free DNA (cf-DNA) Testing Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.11 South America Cell-Free DNA (cf-DNA) Testing Sales Volume (2015-2020)
3.11.1 South America Cell-Free DNA (cf-DNA) Testing Sales Volume Growth Rate (2015-2020)
3.11.2 South America Cell-Free DNA (cf-DNA) Testing Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.12 Rest of the World Cell-Free DNA (cf-DNA) Testing Sales Volume (2015-2020)
3.12.1 Rest of the World Cell-Free DNA (cf-DNA) Testing Sales Volume Growth Rate (2015-2020)
3.12.2 Rest of the World Cell-Free DNA (cf-DNA) Testing Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4 North America
4.1 North America Cell-Free DNA (cf-DNA) Testing Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Cell-Free DNA (cf-DNA) Testing Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Cell-Free DNA (cf-DNA) Testing Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Cell-Free DNA (cf-DNA) Testing Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Cell-Free DNA (cf-DNA) Testing Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Cell-Free DNA (cf-DNA) Testing Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Cell-Free DNA (cf-DNA) Testing Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Cell-Free DNA (cf-DNA) Testing Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Cell-Free DNA (cf-DNA) Testing Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Cell-Free DNA (cf-DNA) Testing Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Cell-Free DNA (cf-DNA) Testing Sales Volume Market Share by Type (2015-2020)
14.2 Global Cell-Free DNA (cf-DNA) Testing Sales Revenue Market Share by Type (2015-2020)
14.3 Global Cell-Free DNA (cf-DNA) Testing Sales Price by Type (2015-2020)
15 Consumption Analysis by Application
15.1 Global Cell-Free DNA (cf-DNA) Testing Consumption Volume by Application (2015-2020)
15.2 Global Cell-Free DNA (cf-DNA) Testing Consumption Value by Application (2015-2020)
16 Company Profiles and Key Figures in Cell-Free DNA (cf-DNA) Testing Business
16.1 Agilent Technology
16.1.1 Agilent Technology Company Profile
16.1.2 Agilent Technology Cell-Free DNA (cf-DNA) Testing Product Specification
16.1.3 Agilent Technology Cell-Free DNA (cf-DNA) Testing Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.2 Invited
16.2.1 Invited Company Profile
16.2.2 Invited Cell-Free DNA (cf-DNA) Testing Product Specification
16.2.3 Invited Cell-Free DNA (cf-DNA) Testing Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.3 Biodesix
16.3.1 Biodesix Company Profile
16.3.2 Biodesix Cell-Free DNA (cf-DNA) Testing Product Specification
16.3.3 Biodesix Cell-Free DNA (cf-DNA) Testing Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.4 Allenex
16.4.1 Allenex Company Profile
16.4.2 Allenex Cell-Free DNA (cf-DNA) Testing Product Specification
16.4.3 Allenex Cell-Free DNA (cf-DNA) Testing Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.5 Illumania
16.5.1 Illumania Company Profile
16.5.2 Illumania Cell-Free DNA (cf-DNA) Testing Product Specification
16.5.3 Illumania Cell-Free DNA (cf-DNA) Testing Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.6 Biocept
16.6.1 Biocept Company Profile
16.6.2 Biocept Cell-Free DNA (cf-DNA) Testing Product Specification
16.6.3 Biocept Cell-Free DNA (cf-DNA) Testing Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.7 Quest Diagnostics
16.7.1 Quest Diagnostics Company Profile
16.7.2 Quest Diagnostics Cell-Free DNA (cf-DNA) Testing Product Specification
16.7.3 Quest Diagnostics Cell-Free DNA (cf-DNA) Testing Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.8 Guardant Health
16.8.1 Guardant Health Company Profile
16.8.2 Guardant Health Cell-Free DNA (cf-DNA) Testing Product Specification
16.8.3 Guardant Health Cell-Free DNA (cf-DNA) Testing Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.9 CareDx
16.9.1 CareDx Company Profile
16.9.2 CareDx Cell-Free DNA (cf-DNA) Testing Product Specification
16.9.3 CareDx Cell-Free DNA (cf-DNA) Testing Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.10 Natera
16.10.1 Natera Company Profile
16.10.2 Natera Cell-Free DNA (cf-DNA) Testing Product Specification
16.10.3 Natera Cell-Free DNA (cf-DNA) Testing Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.11 Roche
16.11.1 Roche Company Profile
16.11.2 Roche Cell-Free DNA (cf-DNA) Testing Product Specification
16.11.3 Roche Cell-Free DNA (cf-DNA) Testing Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.12 Sequenom
16.12.1 Sequenom Company Profile
16.12.2 Sequenom Cell-Free DNA (cf-DNA) Testing Product Specification
16.12.3 Sequenom Cell-Free DNA (cf-DNA) Testing Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.13 Trovagene
16.13.1 Trovagene Company Profile
16.13.2 Trovagene Cell-Free DNA (cf-DNA) Testing Product Specification
16.13.3 Trovagene Cell-Free DNA (cf-DNA) Testing Production Capacity, Revenue, Price and Gross Margin (2015-2020)
17 Cell-Free DNA (cf-DNA) Testing Manufacturing Cost Analysis
17.1 Cell-Free DNA (cf-DNA) Testing Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Cell-Free DNA (cf-DNA) Testing
17.4 Cell-Free DNA (cf-DNA) Testing Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Cell-Free DNA (cf-DNA) Testing Distributors List
18.3 Cell-Free DNA (cf-DNA) Testing Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Cell-Free DNA (cf-DNA) Testing (2021-2026)
20.2 Global Forecasted Revenue of Cell-Free DNA (cf-DNA) Testing (2021-2026)
20.3 Global Forecasted Price of Cell-Free DNA (cf-DNA) Testing (2015-2026)
20.4 Global Forecasted Production of Cell-Free DNA (cf-DNA) Testing by Region (2021-2026)
20.4.1 North America Cell-Free DNA (cf-DNA) Testing Production, Revenue Forecast (2021-2026)
20.4.2 East Asia Cell-Free DNA (cf-DNA) Testing Production, Revenue Forecast (2021-2026)
20.4.3 Europe Cell-Free DNA (cf-DNA) Testing Production, Revenue Forecast (2021-2026)
20.4.4 South Asia Cell-Free DNA (cf-DNA) Testing Production, Revenue Forecast (2021-2026)
20.4.5 Southeast Asia Cell-Free DNA (cf-DNA) Testing Production, Revenue Forecast (2021-2026)
20.4.6 Middle East Cell-Free DNA (cf-DNA) Testing Production, Revenue Forecast (2021-2026)
20.4.7 Africa Cell-Free DNA (cf-DNA) Testing Production, Revenue Forecast (2021-2026)
20.4.8 Oceania Cell-Free DNA (cf-DNA) Testing Production, Revenue Forecast (2021-2026)
20.4.9 South America Cell-Free DNA (cf-DNA) Testing Production, Revenue Forecast (2021-2026)
20.4.10 Rest of the World Cell-Free DNA (cf-DNA) Testing Production, Revenue Forecast (2021-2026)
20.5 Forecast by Type and by Application (2021-2026)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
20.5.2 Global Forecasted Consumption of Cell-Free DNA (cf-DNA) Testing by Application (2021-2026)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Cell-Free DNA (cf-DNA) Testing by Country
21.2 East Asia Market Forecasted Consumption of Cell-Free DNA (cf-DNA) Testing by Country
21.3 Europe Market Forecasted Consumption of Cell-Free DNA (cf-DNA) Testing by Countriy
21.4 South Asia Forecasted Consumption of Cell-Free DNA (cf-DNA) Testing by Country
21.5 Southeast Asia Forecasted Consumption of Cell-Free DNA (cf-DNA) Testing by Country
21.6 Middle East Forecasted Consumption of Cell-Free DNA (cf-DNA) Testing by Country
21.7 Africa Forecasted Consumption of Cell-Free DNA (cf-DNA) Testing by Country
21.8 Oceania Forecasted Consumption of Cell-Free DNA (cf-DNA) Testing by Country
21.9 South America Forecasted Consumption of Cell-Free DNA (cf-DNA) Testing by Country
21.10 Rest of the world Forecasted Consumption of Cell-Free DNA (cf-DNA) Testing by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer